MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Assets Average (2016 - 2026)

MetaVia's (MTVA) quarterly Assets Average came in at $12.9 million in Q4 2025, down 32.59% YoY from $19.2 million in Q4 2024, and down 22.08% on a QoQ basis from $16.6 million in Q3 2025.

MetaVia (MTVA) Assets Average (2016 - 2026) Analysis & Trends

MetaVia (MTVA) has 10 years of Assets Average data on file, last reported at $12.9 million in Q4 2025.

  • Quarterly Assets Average fell 32.59% year-over-year to $12.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $12.9 million (down 32.59% YoY) and the FY2025 annual result came in at $13.7 million, down 29.86% from the prior year.
  • Assets Average eased to $12.9 million in Q4 2025, from $16.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $32.5 million in Q1 2023 to a low of $8.8 million in Q3 2022.
  • A 5-year average of $18.2 million and a median of $16.0 million in 2025 frame the typical range for Assets Average.
  • Annual changes were most pronounced in 2023 — Assets Average jumped 215.23% — and 2024, when it sank 38.79%.
  • Tracing MTVA's Assets Average over 5 years: stood at $12.4 million in 2021, then jumped by 65.18% to $20.5 million in 2022, then rose by 19.75% to $24.6 million in 2023, then retreated by 21.95% to $19.2 million in 2024, then plunged by 32.59% to $12.9 million in 2025.
  • The last three Assets Average figures came in at $12.9 million (Q4 2025), $16.6 million (Q3 2025), and $15.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.22 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 8.86 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.34 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.27 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.09 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 MetaVia 8.72 Mn -3.92 Mn - 12.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.20 Mn
Dec 31, 2025 12.94 Mn
Sep 30, 2025 16.61 Mn
Jun 30, 2025 15.29 Mn
Mar 31, 2025 14.19 Mn
Dec 31, 2024 19.20 Mn
Sep 30, 2024 25.45 Mn
Jun 30, 2024 22.88 Mn
Mar 31, 2024 19.90 Mn
Dec 31, 2023 24.60 Mn
Sep 30, 2023 27.80 Mn
Jun 30, 2023 30.33 Mn
Mar 31, 2023 32.51 Mn
Dec 31, 2022 20.55 Mn
Sep 30, 2022 8.82 Mn
Jun 30, 2022 11.77 Mn
Mar 31, 2022 15.13 Mn
Dec 31, 2021 12.44 Mn
Sep 30, 2021 9.40 Mn
Jun 30, 2021 12.44 Mn